Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zhiyong Lyu, Jing Li, Jinghui Zhen, Wei Shi, Qingying Meng, Wei Zhou, Jingyun An, Kaihu Yao & Fang Dong. (2023) A Hospital-Based and Cross-Sectional Investigation on Clinical Characteristics of Pediatric Streptococcus pneumoniae Isolates in Beijing from 2015 to 2021. Infection and Drug Resistance 16, pages 499-508.
Read now
Read now
Josef Yayan. (2014) The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae
. Drug Design, Development and Therapy 8, pages 1733-1743.
Read now
Read now
Shijun Liu, Erping Xu, Yan Liu, Yuyang Xu, Jun Wang, Jian Du, Xiaoping Zhang, Xinren Che & Wenwen Gu. (2014) Factors associated with pneumococcal vaccination among an urban elderly population in China. Human Vaccines & Immunotherapeutics 10:10, pages 2994-2999.
Read now
Read now
Cristiana M Nascimento-Carvalho. (2010) Pharmacotherapy of childhood pneumonia. Expert Opinion on Pharmacotherapy 11:2, pages 225-231.
Read now
Read now
Articles from other publishers (26)
María Rosario Pérez-Torres Lobato, Marta Mejías Trueba, Héctor Rodríguez Ramallo, Concepción Álvarez del Vayo Benito, María del Carmen Iglesias Aguilar & Mirella Gaboli. (2021) Tratamiento prolongado con ampicilina inhalada en pacientes pediátricos con bronquiectasias no relacionadas con la fibrosis quística. Archivos de Bronconeumología 57:10, pages 662-664.
Crossref
Crossref
María Rosario Pérez-Torres Lobato, Marta Mejías Trueba, Héctor Rodríguez Ramallo, Concepción Álvarez del Vayo Benito, Maria del Carmen Iglesias Aguilar & Mirella Gaboli. (2021) Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis. Archivos de Bronconeumología (English Edition) 57:10, pages 662-664.
Crossref
Crossref
Shinya Tsuzuki, Takayuki Akiyama, Nobuaki Matsunaga, Koji Yahara, Keigo Shibayama, Motoyuki Sugai & Norio Ohmagari. (2020) Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013–18. PLOS ONE 15:10, pages e0240655.
Crossref
Crossref
Malik Sallam. (2019) Trends in Antimicrobial Drug Resistance of Streptococcus pneumoniae Isolates at Jordan University Hospital (2000–2018). Antibiotics 8:2, pages 41.
Crossref
Crossref
Yanpeng Shi, Kai Jiang, Ran Zheng, Jiaxu Fu, Liuqing Yan, Qiang Gu, Yumin Zhang & Feng Lin. (2019) Design, Microwave‐Assisted Synthesis and in Vitro Antibacterial and Antifungal Activity of 2,5‐Disubstituted Benzimidazole. Chemistry & Biodiversity 16:3, pages e1800510.
Crossref
Crossref
Hao-Yuan Lee, Tsu-Lan Wu, Lin-Hui Su, Hsin-Chieh Li, Rajendra Prasad Janapatla, Chyi-Liang Chen & Cheng-Hsun Chiu. (2018) Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan. Journal of Microbiology, Immunology and Infection 51:4, pages 500-509.
Crossref
Crossref
Salam El Ashkar, Marwan Osman, Rayane Rafei, Hassan Mallat, Marcel Achkar, Fouad Dabboussi & Monzer Hamze. (2017) Molecular detection of genes responsible for macrolide resistance among Streptococcus pneumoniae isolated in North Lebanon. Journal of Infection and Public Health 10:6, pages 745-748.
Crossref
Crossref
Catia Cillóniz, Carmen Ardanuy, Jordi Vila & Antoni Torres. (2016) What is the clinical relevance of drug-resistant pneumococcus?. Current Opinion in Pulmonary Medicine 22:3, pages 227-234.
Crossref
Crossref
Arnab Majhi, Kiran Kundu, Rana Adhikary, Madhubanti Banerjee, Sayantika Mahanti, Anirban Basu & Biswadev Bishayi. (2014) Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice. Journal of Inflammation 11:1.
Crossref
Crossref
Arnab Majhi, Rana Adhikary, Aritra Bhattacharyya, Sayantika Mahanti & Biswadev Bishayi. (2014) Levofloxacin-Ceftriaxone Combination Attenuates Lung Inflammation in a Mouse Model of Bacteremic Pneumonia Caused by Multidrug-Resistant Streptococcus pneumoniae via Inhibition of Cytolytic Activities of Pneumolysin and Autolysin. Antimicrobial Agents and Chemotherapy 58:9, pages 5164-5180.
Crossref
Crossref
Sofia Maraki & Ioannis S. Papadakis. (2014) Antimicrobial Resistance Trends among Community-Acquired Respiratory Tract Pathogens in Greece, 2009–2012. The Scientific World Journal 2014, pages 1-7.
Crossref
Crossref
Francesco Blasi, Javier Garau, Jesús Medina, Marco Ávila, Kyle McBride & Helmut Ostermann. (2013) Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respiratory Research 14:1, pages 44.
Crossref
Crossref
W Abdullah Brooks. 2013. Hunter's Tropical Medicine and Emerging Infectious Disease. Hunter's Tropical Medicine and Emerging Infectious Disease
407
415
.
Ashraf Tavanaee Sani, Maryam Mojtabavi & Kiarash Ghazvini. (2012) Prevalence of Ceftriaxon-Sensitive Pneumococci Infection and Use of E- Test for Patients Admitted to Ghaem and Imam Reza Hospitals During a Two-Year Period. Archives of Clinical Infectious Diseases 7:3, pages 85-7.
Crossref
Crossref
Paul M. Tulkens, Pierre Arvis & Frank Kruesmann. (2012) Moxifloxacin Safety. Drugs in R&D 12:2, pages 71-100.
Crossref
Crossref
Chunjiang Zhao, Hongli Sun, Hui Wang, Yudong Liu, Bijie Hu, Yunsong Yu, Ziyong Sun, Yunzhuo Chu, Bin Cao, Kang Liao, Jin'e Lei, Zhidong Hu, Liyan Zhang, Xiaobing Zhang, Yingchun Xu, Zhanwei Wang & Minjun Chen. (2012) Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005–2010). Diagnostic Microbiology and Infectious Disease 73:2, pages 174-181.
Crossref
Crossref
Paul M. Tulkens, Pierre Arvis & Frank Kruesmann. (2012) Moxifloxacin Safety. Drugs in R&D 12:2, pages 71-100.
Crossref
Crossref
T. Welte. (2011) Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality. European Journal of Clinical Microbiology & Infectious Diseases 31:1, pages 33-47.
Crossref
Crossref
Charles Feldman & Ronald Anderson. (2011) Bacteraemic Pneumococcal Pneumonia. Drugs 71:2, pages 131-153.
Crossref
Crossref
Donald J. AbrahamSebastian A. Testero, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
257
402
.
Angel Vila-Corcoles, Ferran Bejarano-Romero, Elisabeth Salsench, Olga Ochoa-Gondar, Cinta de Diego, Frederic Gomez-Bertomeu, Xavier Raga-Luria, Xavier Cliville-Guasch & Victoria Arija. (2009) Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. BMC Infectious Diseases 9:1.
Crossref
Crossref
Jeremy T. Starr, Richard J. Sciotti, Debra L. Hanna, Michael D. Huband, Lisa M. Mullins, Hongliang Cai, Jeffrey W. Gage, Mandy Lockard, Mark R. Rauckhorst, Robert M. Owen, Manjinder S. Lall, Mark Tomilo, Huifen Chen, Sandra P. McCurdy & Michael R. Barbachyn. (2009) 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV. Bioorganic & Medicinal Chemistry Letters 19:18, pages 5302-5306.
Crossref
Crossref
L.-H. Su, T.-L. Wu, A.-J. Kuo, J.-H. Chia & C.-H. Chiu. (2009) Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18. Journal of Antimicrobial Chemotherapy 64:2, pages 336-342.
Crossref
Crossref
Nguyen Quynh Hoa, Mattias Larson, Nguyen Thi Kim Chuc, Bo Eriksson, Nguyen Vu Trung & Cecilia Lundborg Stålsby. (2009) Antibiotics and paediatric acute respiratory infections in rural Vietnam: health-care providers’ knowledge, practical competence and reported practice. Tropical Medicine & International Health 14:5, pages 546-555.
Crossref
Crossref
Knut Ohlsen, Gudrun Dandekar, Roland Schwarz & Thomas Dandekar. (2008) New trends in pharmacogenomic strategies against resistance development in microbial infections. Pharmacogenomics 9:11, pages 1711-1723.
Crossref
Crossref
Bruno Leal, Ilídio F. Afonso, Carlos R. Rodrigues, Paula A. Abreu, Rafael Garrett, Luiz Carlos S. Pinheiro, Alexandre R. Azevedo, Julio C. Borges, Percilene F. Vegi, Cláudio C.C. Santos, Francisco C.A. da Silveira, Lúcio M. Cabral, Izabel C.P.P. Frugulhetti, Alice M.R. Bernardino, Dilvani O. Santos & Helena C. Castro. (2008) Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure–activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives. Bioorganic & Medicinal Chemistry 16:17, pages 8196-8204.
Crossref
Crossref